216 related articles for article (PubMed ID: 36675261)
1. IL-17A Enhances Retinal Neovascularization.
Taylor BE; Lee CA; Zapadka TE; Zhou AY; Barber KG; Taylor ZRR; Howell SJ; Taylor PR
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675261
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of the Nuclear Receptor RORγ and Interleukin-17A Suppresses Neovascular Retinopathy: Involvement of Immunocompetent Microglia.
Talia DM; Deliyanti D; Agrotis A; Wilkinson-Berka JL
Arterioscler Thromb Vasc Biol; 2016 Jun; 36(6):1186-96. PubMed ID: 27055905
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-17A neutralization alleviated ocular neovascularization by promoting M2 and mitigating M1 macrophage polarization.
Zhu Y; Tan W; Demetriades AM; Cai Y; Gao Y; Sui A; Lu Q; Shen X; Jiang C; Xie B; Sun X
Immunology; 2016 Apr; 147(4):414-28. PubMed ID: 26694999
[TBL] [Abstract][Full Text] [Related]
4. Blocking IL-17A Alleviates Diabetic Retinopathy in Rodents.
Qiu AW; Liu QH; Wang JL
Cell Physiol Biochem; 2017; 41(3):960-972. PubMed ID: 28222445
[TBL] [Abstract][Full Text] [Related]
5. Diabetes-mediated IL-17A enhances retinal inflammation, oxidative stress, and vascular permeability.
Sigurdardottir S; Zapadka TE; Lindstrom SI; Liu H; Taylor BE; Lee CA; Kern TS; Taylor PR
Cell Immunol; 2019 Jul; 341():103921. PubMed ID: 31076079
[TBL] [Abstract][Full Text] [Related]
6. Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy.
Watanabe D; Suzuma K; Matsui S; Kurimoto M; Kiryu J; Kita M; Suzuma I; Ohashi H; Ojima T; Murakami T; Kobayashi T; Masuda S; Nagao M; Yoshimura N; Takagi H
N Engl J Med; 2005 Aug; 353(8):782-92. PubMed ID: 16120858
[TBL] [Abstract][Full Text] [Related]
7. Nox (NADPH Oxidase) 1, Nox4, and Nox5 Promote Vascular Permeability and Neovascularization in Retinopathy.
Deliyanti D; Alrashdi SF; Touyz RM; Kennedy CR; Jha JC; Cooper ME; Jandeleit-Dahm KA; Wilkinson-Berka JL
Hypertension; 2020 Apr; 75(4):1091-1101. PubMed ID: 32114846
[TBL] [Abstract][Full Text] [Related]
8. Attenuation of streptozotocin-induced diabetic retinopathy with low molecular weight fucoidan via inhibition of vascular endothelial growth factor.
Yang W; Yu X; Zhang Q; Lu Q; Wang J; Cui W; Zheng Y; Wang X; Luo D
Exp Eye Res; 2013 Oct; 115():96-105. PubMed ID: 23810809
[TBL] [Abstract][Full Text] [Related]
9. Anti-IL17A Halts the Onset of Diabetic Retinopathy in Type I and II Diabetic Mice.
Zhou AY; Taylor BE; Barber KG; Lee CA; Taylor ZRR; Howell SJ; Taylor PR
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674854
[TBL] [Abstract][Full Text] [Related]
10. Diabetes induces IL-17A-Act1-FADD-dependent retinal endothelial cell death and capillary degeneration.
Lindstrom SI; Sigurdardottir S; Zapadka TE; Tang J; Liu H; Taylor BE; Smith DG; Lee CA; DeAngelis J; Kern TS; Taylor PR
J Diabetes Complications; 2019 Sep; 33(9):668-674. PubMed ID: 31239234
[TBL] [Abstract][Full Text] [Related]
11. RORγt Inhibitor-SR1001 Halts Retinal Inflammation, Capillary Degeneration, and the Progression of Diabetic Retinopathy.
Zapadka TE; Lindstrom SI; Taylor BE; Lee CA; Tang J; Taylor ZRR; Howell SJ; Taylor PR
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32429598
[TBL] [Abstract][Full Text] [Related]
12. Placental growth factor and its potential role in diabetic retinopathy and other ocular neovascular diseases.
Nguyen QD; De Falco S; Behar-Cohen F; Lam WC; Li X; Reichhart N; Ricci F; Pluim J; Li WW
Acta Ophthalmol; 2018 Feb; 96(1):e1-e9. PubMed ID: 27874278
[TBL] [Abstract][Full Text] [Related]
13. Ischaemia-induced retinal neovascularisation and diabetic retinopathy in mice with conditional knockout of hypoxia-inducible factor-1 in retinal Müller cells.
Lin M; Chen Y; Jin J; Hu Y; Zhou KK; Zhu M; Le YZ; Ge J; Johnson RS; Ma JX
Diabetologia; 2011 Jun; 54(6):1554-66. PubMed ID: 21360191
[TBL] [Abstract][Full Text] [Related]
14. Aryl Hydrocarbon Receptor Agonist VAF347 Impedes Retinal Pathogenesis in Diabetic Mice.
Zapadka TE; Lindstrom SI; Batoki JC; Lee CA; Taylor BE; Howell SJ; Taylor PR
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33919327
[TBL] [Abstract][Full Text] [Related]
15. Neutrophil elastase contributes to the pathological vascular permeability characteristic of diabetic retinopathy.
Liu H; Lessieur EM; Saadane A; Lindstrom SI; Taylor PR; Kern TS
Diabetologia; 2019 Dec; 62(12):2365-2374. PubMed ID: 31612267
[TBL] [Abstract][Full Text] [Related]
16. Both Autocrine Signaling and Paracrine Signaling of HB-EGF Enhance Ocular Neovascularization.
Inoue Y; Shimazawa M; Nakamura S; Takata S; Hashimoto Y; Izawa H; Masuda T; Tsuruma K; Sakaue T; Nakayama H; Higashiyama S; Hara H
Arterioscler Thromb Vasc Biol; 2018 Jan; 38(1):174-185. PubMed ID: 29191924
[TBL] [Abstract][Full Text] [Related]
17. [Aging and retinal vascular diseases].
Takagi H
Nippon Ganka Gakkai Zasshi; 2007 Mar; 111(3):207-30; discussion 231. PubMed ID: 17402563
[TBL] [Abstract][Full Text] [Related]
18. Thioredoxin-interacting protein deficiency ameliorates diabetic retinal angiogenesis.
Duan J; Du C; Shi Y; Liu D; Ma J
Int J Biochem Cell Biol; 2018 Jan; 94():61-70. PubMed ID: 29203232
[TBL] [Abstract][Full Text] [Related]
19. Long-term retinal PEDF overexpression prevents neovascularization in a murine adult model of retinopathy.
Haurigot V; Villacampa P; Ribera A; Bosch A; Ramos D; Ruberte J; Bosch F
PLoS One; 2012; 7(7):e41511. PubMed ID: 22911805
[TBL] [Abstract][Full Text] [Related]
20. Bone morphogenetic protein 2: a potential new player in the pathogenesis of diabetic retinopathy.
Hussein KA; Choksi K; Akeel S; Ahmad S; Megyerdi S; El-Sherbiny M; Nawaz M; Abu El-Asrar A; Al-Shabrawey M
Exp Eye Res; 2014 Aug; 125():79-88. PubMed ID: 24910902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
